Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Schwartz

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
St. Thomas Law Review|March 29, 2003
Genetic breakthroughs and the limits of medicine: short stature, growth hormone, and the idea of dysfunctionP H Schwartz
The Journal of Psychohistory|April 1, 1985
The maternal Christ as redeemer: speech and gender in the thought of Martin LutherP H Schwartz
The American Journal of Bioethics : AJOB|April 28, 2009
Ethical challenges to cell-based interventions for the central nervous system: some recommendations for clinical trials and practiceP H Schwartz, M W Kalichman
Research Communications in Chemical Pathology and Pharmacology|August 1, 1991
Cardiac arrest and resuscitation alters the pharmacokinetics of MK-801 in the ratP H Schwartz, C G Wasterlain
Journal of the Neurological Sciences|March 1, 1993
Determination of serum and brain concentrations of neuroprotective and non-neuroprotective doses of MK-801P H Schwartz, C G Wasterlain
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1991
The pharmacokinetics of dobutamine in pediatric intensive care unit patientsP H Schwartz, M K Eldadah, C J Newth
Critical Care Medicine|January 1, 1993
Pharmacokinetics of exogenous epinephrine in critically ill childrenD G Fisher, P H Schwartz, A L Davis
European Journal of Pharmacology|March 3, 1992
Felbamate reduces hypoxic-ischemic brain damage in vivoC G Wasterlain, L M Adams, H Hattori, et al.
Pediatric Research|December 1, 1985
Investigation of an animal model of a Reye-like syndrome caused by Margosa oilD Sinniah, P H Schwartz, R A Mitchell, et al.
Critical Care Medicine|August 1, 1991
Pharmacokinetics of dopamine in infants and childrenM K Eldadah, P H Schwartz, R Harrison, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
St. Thomas Law Review|March 29, 2003
Genetic breakthroughs and the limits of medicine: short stature, growth hormone, and the idea of dysfunctionP H Schwartz
The Journal of Psychohistory|April 1, 1985
The maternal Christ as redeemer: speech and gender in the thought of Martin LutherP H Schwartz
The American Journal of Bioethics : AJOB|April 28, 2009
Ethical challenges to cell-based interventions for the central nervous system: some recommendations for clinical trials and practiceP H Schwartz, M W Kalichman
Research Communications in Chemical Pathology and Pharmacology|August 1, 1991
Cardiac arrest and resuscitation alters the pharmacokinetics of MK-801 in the ratP H Schwartz, C G Wasterlain
Journal of the Neurological Sciences|March 1, 1993
Determination of serum and brain concentrations of neuroprotective and non-neuroprotective doses of MK-801P H Schwartz, C G Wasterlain
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1991
The pharmacokinetics of dobutamine in pediatric intensive care unit patientsP H Schwartz, M K Eldadah, C J Newth
Critical Care Medicine|January 1, 1993
Pharmacokinetics of exogenous epinephrine in critically ill childrenD G Fisher, P H Schwartz, A L Davis
European Journal of Pharmacology|March 3, 1992
Felbamate reduces hypoxic-ischemic brain damage in vivoC G Wasterlain, L M Adams, H Hattori, et al.
Pediatric Research|December 1, 1985
Investigation of an animal model of a Reye-like syndrome caused by Margosa oilD Sinniah, P H Schwartz, R A Mitchell, et al.
Critical Care Medicine|August 1, 1991
Pharmacokinetics of dopamine in infants and childrenM K Eldadah, P H Schwartz, R Harrison, et al.
Pageof 2